申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US04713465A1
公开(公告)日:1987-12-15
Halogenohydroxyflavones ##STR1## in which R is alkyl having 1-3 C atoms, X is F, Cl, Br or I, and m, n and p are each 1, 2 or 3, and their esters with sulfuric acid and phosphoric acid, and the salts of these compounds, are suitable for the treatment of hyperthyroidism.
卤代羟基黄酮类化合物##STR1##中,R为含有1-3个碳原子的烷基,X为F、Cl、Br或I,m、n和p分别为1、2或3,以及它们与硫酸和磷酸的酯类,以及这些化合物的盐,适用于治疗甲状腺功能亢进症。